This study is testing an electronic alert system to help doctors prevent blood clots (Venous Thromboembolism or VTE) in hospitalized patients. The alert, called an electronic alert, pops up on the doctor's screen to remind them about a patient's risk for VTE after leaving the hospital and if they might need medication to prevent clots. The goal is to see how often doctors prescribe extended-duration betrixaban, a medication that helps prevent clots, after patients are discharged. You may be able to join if you are at least 40 years old, hospitalized for a serious medical condition (like heart failure or infection), have limited movement, are not already on clot-preventing medicine when you leave the hospital, and have an additional risk factor like being over 60, having a history of VTE, or cancer. The study aims to enroll 400 participants.

Study design

This is a randomized controlled trial conducted at a single center in the U.S., involving 400 participants. Half of the participants' doctors will receive the electronic alert, and half will not.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will track the frequency of prescriptions for extended-duration clot prevention medication for 90 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.